Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
U.S. Urinary Incontinence Therapeutics Market Size, Share & Trends Analysis Report By Type (Stress Incontinence, Urge Incontinence), By Drug Class, By Gender, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. urinary incontinence therapeutics market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 2.41 billion by 2033, growing at a CAGR of 5.06% from 2025 to 2033. The U...
November 2025
150 pages
Asia Pacific Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific bacterial vaginosis (BV) drug market is projected to experience significant growth, with an expected market size of approximately US$ 691.1 million by 2031, up from US$ 380.6 million...
November 2025
167 pages
Asia Pacific Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 508.7 billion by 2031, up from US$ 304.0 billion in 2024. This growth represents a compound ann...
November 2025
230 pages
Europe Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 1,060.6 million by 2031, up from US$ 607.2 million in 2024. This growth represents a compo...
November 2025
165 pages
Europe Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 537.6 billion by 2031, up from US$ 335.0 billion in 2024, reflecting a compound annual growth rate (C...
November 2025
225 pages
Middle East & Africa Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East and Africa Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 150.5 million by 2031, up from US$ 89.7 million in 2024. This growth repre...
November 2025
156 pages
Middle East & Africa Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East & Africa (MEA) Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 64.4 billion by 2031, up from US$ 41.7 billion in 2024. This growth represents a...
November 2025
218 pages
North America Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The North America Bacterial Vaginosis Drug Market is projected to grow significantly, reaching an estimated US$ 1,688.3 million by 2031, up from US$ 942.6 million in 2024. This growth represents a com...
November 2025
143 pages
North America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The North America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 1,157.0 billion by 2031, up from US$ 707.7 billion in 2024, reflecting a compound annual growt...
November 2025
210 pages
South & Central America Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The South and Central America Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 236.6 million by 2031, up from US$ 139.1 million in 2024. This growth r...
November 2025
149 pages
South & Central America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The South & Central America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 82.5 billion by 2031, up from US$ 52.5 billion in 2024. This growth represents a com...
November 2025
212 pages
Global Testosterone Replacement Therapy Market - 2025-2033
US$ 3,400.00
Global Testosterone Replacement Therapy Market reached US$1.98Billion in 2024 and is expected to reach US$2.74Billion by 2033, growing with a CAGR of 7.70% during the forecast period 2026-2033. The Gl...
November 2025
65 pages
Global Thrombocytopenia Management Market - 2025-2033
US$ 3,400.00
Global Thrombocytopenia Management Marketis is growing with a CAGR of 7.70% during the forecast period 2026-2035. The Global Thrombocytopenia Management Market emerges as a key focus in DataM Intellig...
November 2025
60 pages
Nucleoside Analogues Market - 2024-2031
US$ 3,400.00
The Nucleoside Analogues Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
November 2025
46 pages
Immunotherapy Drugs: Global Markets
US$ 4,650.00
The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% duri...
November 2025
231 pages
Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service (Patient Recruitment & Registry Services, Patient Retention Services), By Phase, By Therapeutic Area, By Age Group, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global clinical trial patient recruitment services market size was valued at USD 10.99 billion in 2024 and is projected to reach USD 22.85 billion by 2033, growing at a CAGR of 8.72% from 2025 to...
November 2025
150 pages
Global Copovidone Market Growth 2025-2031
US$ 3,660.00
The global Copovidone market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The solid product of copovidone is a whi...
November 2025
142 pages
Global Cellulose Acetate Tablet Market Growth 2025-2031
US$ 3,660.00
The global Cellulose Acetate Tablet market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Cellulose Acetate Tablet i...
November 2025
114 pages
Global Iohexol Hydrolysate Market Growth 2025-2031
US$ 3,660.00
The global Iohexol Hydrolysate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Iohexo...
November 2025
82 pages
Global N-DesMethyl IoMeprol Market Growth 2025-2031
US$ 3,660.00
The global N-DesMethyl IoMeprol market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for N-Des...
November 2025
79 pages
Global Phenylbutazone API Market Growth 2025-2031
US$ 3,660.00
The global Phenylbutazone API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Phenylb...
November 2025
89 pages
Advanced Therapy Medicinal Products CDMO Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication
US$ 3,950.00
The Advanced Therapy Medicinal Products CDMO Market is valued at USD 6.49 billion in 2025 and is projected to grow at a CAGR of 15.8% to reach USD 24.3 billion by 2034. Advanced Therapy Medicinal Prod...
November 2025
160 pages
Pharma HUB And Patient Access Support Service Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Program Enrolment, Order processing, Application processing, Ease of enrolment, Program data, Treatment Navigators, Process flows, Program literature and scripts, Care team training, Systems testing and optimization, Reimbursement Service, Clinical Educator, Dispensing, Others), By Delivery (Integrated Services, Standalone Services)
US$ 3,950.00
The Pharma HUB And Patient Access Support Service Market is valued at USD 3.6 billion in 2025 and is projected to grow at a CAGR of 11% to reach USD 9.21 billion by 2034. Pharma HUB And Patient Access...
November 2025
160 pages
Pharmaceutical Contract Manufacturing And Research Services Market Outlook 2026-2034: Market Share, and Growth Analysis By Service (Manufacturing, Research, Oncology, Vaccines, Inflammation & Immunology, Cardiology, Neuroscience, Others), By Research (Oncology, Vaccines, Inflammation and Immunology, Cardiology, Neuroscience, Others)
US$ 3,950.00
The Pharmaceutical Contract Manufacturing And Research Services Market is valued at USD 337.2 billion in 2025 and is projected to grow at a CAGR of 6.2% to reach USD 579.4 billion by 2034. Pharmaceuti...
November 2025
160 pages
Psychedelic API Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (API-Grade Psilocybin, API-Grade DMT, LSD API, Ketamine API, Others), By API Compound (Active Plant Components, Novel Synthetic Compounds, Metabolites, Isotopically Labelled Standards), By Source, By Grade, By Application
US$ 3,950.00
The Psychedelic API Market is valued at USD 2.01 billion in 2025 and is projected to grow at a CAGR of 11.8% to reach USD 5.48 billion by 2034. Psychedelic API Market The Psychedelic API market covers...
November 2025
160 pages
Global Talaporfin Sodium Market Growth 2025-2031
US$ 3,660.00
The global Talaporfin Sodium market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Talaporf...
November 2025
96 pages
Global Dronedarone Hydrochloride Market Growth 2025-2031
US$ 3,660.00
The global Dronedarone Hydrochloride market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for...
November 2025
89 pages
